Medical Devices Startups

ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs. The company is focused on rare genetic conditions including cystic fibrosis and primary ciliary dyskinesia.

10 investors

Restore Vis is a life sciences company founded by a vitreoretinal surgeon and clinician scientist focused on addressing inflammation, aging, neurodegeneration and angiogenesis through translational research from drug discovery to clinical trials. The company develops treatments for ophthalmology and vision-related conditions.

10 investors

Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis. The company produces medical devices for orthopedic shoulder procedures.

10 investors

Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.

10 investors

Trexo develops a robotic device that enables children with cerebral palsy and other mobility disabilities to walk independently at home. The device is designed for use by children, parents, and physiotherapists, combining therapeutic function with home accessibility.

10 investors

Visby offers an FDA-authorized at-home PCR test kit for women's sexual health that detects chlamydia, gonorrhea, and trichomoniasis from a single swab, delivering private results via a mobile app in about 30 minutes with included same-day telehealth for positive results. The product is sold direct to consumers in the U.S. for users 14 and older.

10 investors

Viz.ai uses artificial intelligence to accelerate care coordination in healthcare settings, reducing delays between patients and life-saving treatments. The company transforms clinical workflows to improve patient outcomes.

10 investors

Adyn uses large inclusive datasets and machine learning to advance personalized medicine for historically under-researched health conditions, with initial focus on reproductive disorders. The company aims to close race and gender knowledge gaps in medical research.

9 investors

Akero develops engineered protein therapies for metabolic diseases, particularly MASH (metabolic dysfunction-associated steatohepatitis) and other conditions with high unmet medical need. The company's lead candidate, efruxifermin, is in phase 3 clinical trials for liver disease treatment.

9 investors

Ash provides an end-to-end platform for at-home and in-person health testing, connecting organizations to a network of CLIA-/CAP-certified labs and licensed providers through a single integration. It offers white-label test kits, patient support and engagement, provider-of-record handling, patient portals, and program reporting for organizations running branded health testing programs across the US.

9 investors

Avive develops automated external defibrillators (AEDs) and cardiac emergency response systems designed to improve outcomes for sudden cardiac arrest. The company serves communities, first responders, and institutions seeking accessible, affordable life-saving equipment.

9 investors

Avro Life Sciences develops platform technology for novel drug delivery through passive transdermal administration. The company operates in the biotech sector, focusing on dermatological and systemic therapeutics.

9 investors

Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure. The company also builds a Brain Foundation Model software to decode and interpret neural signals for brain-computer interface applications.

9 investors

bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications. The company markets cells and disease models through its ioCells brand for use in biomedical research and therapeutic development.

9 investors

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment. The company partners with licensed dentists and orthodontists to provide high-quality orthodontic care.

9 investors

Carlsmed develops the aprevo personalized surgery platform for spine fusion procedures, producing patient-specific implants and technology used by spine surgeons. The company operates in the medical device industry with FDA-cleared lumbar and cervical fusion products.

9 investors

Clinikally develops and sells dermatology-backed skin and hair care products for Indian consumers, complemented by online consultations with dermatologists. The company formulates medical-grade products targeting specific skin and hair conditions using high-quality ingredients sourced from Europe and the USA, with efficacy validated through clinical studies.

9 investors

Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.

9 investors

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases. The company uses bioelectronic interfaces and AI to decode the body's neural signals and enable precise, adaptive therapeutic interventions.

9 investors

Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.

9 investors

Eden creates digital products to deliver healthcare services and health solutions to a broad audience. The company focuses on bringing quality healthcare experiences to all through digital innovation.

9 investors

Flatiron Health combines AI-powered technology and clinical expertise with real-world oncology data to help healthcare providers and life science organizations improve cancer care and research. The company operates a global oncology platform serving community oncologists and research institutions across the US, UK, Germany, and Japan.

9 investors

Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.

9 investors

Forescout provides cyber-physical systems security and network access control solutions for IoT, OT, and medical device environments. The company serves enterprises managing IoT and industrial control system security risks.

9 investors